Pakistani Female with Delusional Thought Process Disorder begins Invega Sustenna 234mg IM one time dose followed by 156mg IM on day 4 and monthly thereafter. Why would you choose this medication? (There is 25% decrease in symptoms after patient returns to clinic in 4 weeks. Patient complained about weight gain while on Invega Sustenna). Patient maintained on current dose of Sustenna. What would be your rationale for choosing this decision to maintain current dose of Invega Sustenna 156mg IM every month? What were you hoping to achieve by making this decision?